BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 9137217)

  • 1. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Yamamoto S; Tonami N
    J Am Coll Cardiol; 1997 May; 29(6):1226-33. PubMed ID: 9137217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy.
    Acampa W; Cuocolo A; Petretta M; Bruno A; Castellani M; Finzi A; Gerundini P
    J Nucl Cardiol; 2002; 9(1):33-40. PubMed ID: 11845127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.
    Nicolai E; Cuocolo A; Acampa W; Varrone A; Pace L; Salvatore M
    J Nucl Cardiol; 1999; 6(3):270-7. PubMed ID: 10385182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between rest technetium-99m-tetrofosmin and rest-redistribution thallium-201 SPECT in stable patients with healed myocardial infarction.
    Kula M; Tutus A; Abaci A; Oguzhan A; Arslan SM; Ergin A
    Nucl Med Commun; 2001 Dec; 22(12):1317-24. PubMed ID: 11711902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
    Duncan BH; Ahlberg AW; Levine MG; McGill CC; Mann A; White MP; Mather JF; Waters DD; Heller GV
    Am J Cardiol; 2000 Mar; 85(6):680-4. PubMed ID: 12000040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.
    Sciagrà R; Bisi G; Santoro GM; Zerauschek F; Sestini S; Pedenovi P; Pappagallo R; Fazzini PF
    J Am Coll Cardiol; 1997 Aug; 30(2):384-91. PubMed ID: 9247509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
    J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Tonami N; Hisada K
    Am J Cardiol; 1996 Feb; 77(5):350-4. PubMed ID: 8602561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: additional value of gated SPECT.
    Stollfuss JC; Haas F; Matsunari I; Neverve J; Nekolla S; Ziegler S; Schwaiger M
    J Nucl Med; 1999 Nov; 40(11):1824-31. PubMed ID: 10565777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of myocardial viability using sequential dual-isotope single photon emission tomography imaging with rest TI-201/stress Tc-99m tetrofosmin in the prediction of wall motion recovery after revascularization.
    Fukuzawa S; Inagaki M; Morooka S; Inoue T; Matsumoto Y; Yokoyama K; Ozawa S
    Jpn Circ J; 1997 Jun; 61(6):481-7. PubMed ID: 9225193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
    Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
    J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.
    Sridhara BS; Braat S; Rigo P; Itti R; Cload P; Lahiri A
    Am J Cardiol; 1993 Nov; 72(14):1015-9. PubMed ID: 8213580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.
    Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M
    Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reverse redistribution of technetium-99m-tetrofosmin after acute coronary revascularization in patients with myocardial infarction].
    Arii T; Naruse H; Sakaki T; Masai M; Takahashi K; Ohyanagi M; Iwasaki T; Fukuchi M
    J Cardiol; 1999 Jul; 34(1):1-8. PubMed ID: 10422620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.
    Cuocolo A; Acampa W; Nicolai E; Pace L; Petretta M; Salvatore M
    J Nucl Cardiol; 2000; 7(1):8-15. PubMed ID: 10698229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.
    Udelson JE; Coleman PS; Metherall J; Pandian NG; Gomez AR; Griffith JL; Shea NL; Oates E; Konstam MA
    Circulation; 1994 Jun; 89(6):2552-61. PubMed ID: 8205664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous assessment of myocardial perfusion and ventricular function using thallium-201 at rest/Tc-99m tetrofosmin at effort with single-photon emission computerized tomography, synchronized with electrocardiogram (synchronized SPECT). Initial experience in Latin America].
    Puente A; Alexánderson E; Arroyo A; Lorenzo A; Victoria D
    Arch Inst Cardiol Mex; 2000; 70(5):448-55. PubMed ID: 11534095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium.
    Gunning MG; Anagnostopoulos C; Knight CJ; Pepper J; Burman ED; Davies G; Fox KM; Pennell DJ; Ell PJ; Underwood SR
    Circulation; 1998 Nov; 98(18):1869-74. PubMed ID: 9799206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.